Anodyne Closes Seed+ Financing to Accelerate Commercialization of Green Chemicals

Vancouver, British Columbia – June 5, 2025: Syniad Innovations Inc. (“Syniad”) is pleased to announce that Anodyne Chemistries (the “Company” or “Anodyne”), a leading innovator in sustainable chemical production, has successfully closed its C$6.5M Seed+ equity financing. This significant additional investment will fuel the company’s rapid growth to deliver sustainable, non-toxic feedstocks to the chemical industry using its innovative, nature-inspired technology platform.

Anodyne’s Seed+ financing follows a previously announced raise in April 2024 highlighting the rapid progress of Anodyne’s commercialization strategy.  With an upcoming pilot plant being installed in Vancouver this year, its first commercial deployments are expected to use CO2 captured directly at industrial sites.

Over the past several months, Anodyne has completed a series of industrial projects demonstrating the significant economic value created from its proprietary bioelectric manufacturing process. The Company’s unique approach represents a departure from traditional petrochemistry and fermentation. Specifically, by removing the need for fossil fuel or food-based feedstocks and replacing energy and carbon-intensive processes with bioelectric methods, Anodyne is delivering chemicals that are:

Safer: Eliminating toxic by-products and hazardous operating conditions often associated with conventional chemical manufacturing.

Cost-Competitive: Offering a compelling economic alternative to traditional, fossil-derived chemicals.

Supply Chain Compatible: Offering the same chemicals, with the same characteristics, but at drastically reduced carbon intensity.

Iain Evans, Anodyne’s CEO, commented, “Ever more companies in the chemicals industry are discovering bioelectric manufacturing and finding ways to work with Anodyne to secure the future of their supply chains. A shift away from toxic feedstocks, solvents and by-products makes this an even more compelling proposition. The company’s traction proves that there is significant demand for new methods of chemical production for existing chemicals, and we are very grateful for the additional investment that allows us to accelerate those commercial programs”.

The newly secured capital will be strategically deployed to:

Accelerate the first Multi-Product Pilot Plant (MP3): A crucial step towards demonstrating the versatility, scalability and repeatability of Anodyne’s platform.

Expand product lines: Accelerating the commercial readiness of chemicals requested by industry partners.

Deepening an already robust talent pool: Attracting and retaining top-tier talent from the chemicals industry, and award-winning scientists and engineers to drive further innovation.

Anodyne CTO Manou Davies, added, “I’d like to thank all of Anodyne’s existing shareholders for the support they’ve shown us since our launch. Their foresight into the future, and networks of industry connections has allowed us to better understand our partners challenges, and work with them to find solutions that will be operationally achievable in their supply chains and importantly, commercially attractive. In particular, progress to date simply would not have been possible without the unstinting efforts of the team at Syniad Innovations (our co-founder), which has been such an important differentiator for us ever since launch”.

About Anodyne Chemistries

Anodyne Chemistries is an industrial biotechnology and renewable chemicals company developing a new generation of sustainable chemicals and low-carbon fuels. By uniquely combining synthetic biology and electrochemistry, Anodyne is pioneering bioelectric manufacturing processes that convert CO2 into valuable, environmentally friendly products, thereby fundamentally disrupting the chemical industry’s reliance on fossil fuels. Anodyne’s mission is to empower industries to achieve decarbonization goals while fostering a healthier planet.

For more details, visit: https://anodynechemistries.com/